Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?

Figures

• 

  Fig. 1. Age-specific subgroups in large randomised trials comparing coronary artery bypass grafting versus percutaneous coronary intervention in patients with multivessel disease or left main coronary artery disease. (*1P value for interaction represents likelihood of interaction between age-specific subgroups and revascularisation strategy in each randomised trial. *2Adjusted hazard ratio by covariates. *3Defined as a composite of death, MI, stroke and ischaemia-driven TVR. *4Defined as a composite of death, non-procedural MI, repeat revascularisation and stroke. CABG coronary artery bypass grafting, PCI percutaneous coronary intervention, HR hazard ratio, CI confidence interval, LMCAD left main coronary artery disease, MVD multivessel disease, DM diabetes mellitus, 3VD three-vessel disease, MACCE major adverse cardiac and cerebrovascular events, MI myocardial infarction, TVR target vessel revascularisation)